Low efficiency of the Moloney murine leukemia virus reverse transcriptase during reverse transcription of rare t(8;21) fusion gene transcripts.

PubWeight™: 1.03‹?› | Rank: Top 15%

🔗 View Article (PMID 11962598)

Published in Biotechniques on April 01, 2002

Authors

John Curry1, Cliona McHale, Martyn T Smith

Author Affiliations

1: Department of Immunology, Molecular and Cellular Biology, University of California, Berkeley 94720-3200, USA. curry@uclink4.berkeley.edu

Articles by these authors

(truncated to the top 100)

Epidemiology. Environment and disease risks. Science (2010) 4.64

Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs. Blood (2008) 4.41

Hematotoxicity in workers exposed to low levels of benzene. Science (2004) 4.19

Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol (2006) 4.13

Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium. Am J Epidemiol (2010) 2.86

Genetic variants at 6p21.33 are associated with susceptibility to follicular lymphoma. Nat Genet (2009) 2.73

Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32. Nat Genet (2010) 2.37

Occupational exposure to formaldehyde, hematotoxicity, and leukemia-specific chromosome changes in cultured myeloid progenitor cells. Cancer Epidemiol Biomarkers Prev (2010) 2.34

An emerging role for epigenetic dysregulation in arsenic toxicity and carcinogenesis. Environ Health Perspect (2010) 2.16

Biological sample collection and processing for molecular epidemiological studies. Mutat Res (2003) 2.13

Polymorphisms and haplotypes in folate-metabolizing genes and risk of non-Hodgkin lymphoma. Blood (2004) 1.93

Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. Nat Genet (2013) 1.85

Personalized exposure assessment: promising approaches for human environmental health research. Environ Health Perspect (2005) 1.83

Body mass index, leptin and leptin receptor polymorphisms, and non-hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev (2004) 1.80

Research recommendations for selected IARC-classified agents. Environ Health Perspect (2010) 1.73

In utero origin of t(8;21) AML1-ETO translocations in childhood acute myeloid leukemia. Blood (2002) 1.71

Polymorphisms in the oxidative stress genes, superoxide dismutase, glutathione peroxidase and catalase and risk of non-Hodgkin's lymphoma. Haematologica (2006) 1.64

High-performance single cell genetic analysis using microfluidic emulsion generator arrays. Anal Chem (2010) 1.64

Polymorphisms in the estrogen receptor 1 and vitamin C and matrix metalloproteinase gene families are associated with susceptibility to lymphoma. PLoS One (2008) 1.61

GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma. PLoS Genet (2011) 1.58

Decreased urinary beta-defensin-1 expression as a biomarker of response to arsenic. Toxicol Sci (2008) 1.54

Functional FAS promoter polymorphisms are associated with increased risk of acute myeloid leukemia. Cancer Res (2003) 1.53

Critical windows of exposure to household pesticides and risk of childhood leukemia. Environ Health Perspect (2002) 1.52

Cytogenetics of Hispanic and White children with acute lymphoblastic leukemia in California. Cancer Epidemiol Biomarkers Prev (2006) 1.51

Accuracy of multiplexed Illumina platform-based single-nucleotide polymorphism genotyping compared between genomic and whole genome amplified DNA collected from multiple sources. Cancer Epidemiol Biomarkers Prev (2006) 1.45

Detailed exposure assessment for a molecular epidemiology study of benzene in two shoe factories in China. Ann Occup Hyg (2004) 1.44

Using urinary biomarkers to elucidate dose-related patterns of human benzene metabolism. Carcinogenesis (2005) 1.37

Formaldehyde exposure and leukemia: a new meta-analysis and potential mechanisms. Mutat Res (2008) 1.36

Polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and risk of adult acute lymphocytic leukemia. Blood (2002) 1.34

Toxicogenomic profiling of chemically exposed humans in risk assessment. Mutat Res (2010) 1.30

Individual differences in arsenic metabolism and lung cancer in a case-control study in Cordoba, Argentina. Toxicol Appl Pharmacol (2010) 1.30

Formaldehyde in China: production, consumption, exposure levels, and health effects. Environ Int (2009) 1.28

Arsenic immunotoxicity: a review. Environ Health (2013) 1.27

Current understanding of the mechanism of benzene-induced leukemia in humans: implications for risk assessment. Carcinogenesis (2011) 1.26

Modeling human metabolism of benzene following occupational and environmental exposures. Cancer Epidemiol Biomarkers Prev (2006) 1.26

NQO1 polymorphisms and de novo childhood leukemia: a HuGE review and meta-analysis. Am J Epidemiol (2008) 1.25

Discovery of novel biomarkers by microarray analysis of peripheral blood mononuclear cell gene expression in benzene-exposed workers. Environ Health Perspect (2005) 1.24

The role of inflammation in age-related disease. Aging (Albany NY) (2013) 1.22

Aberrations in chromosomes associated with lymphoma and therapy-related leukemia in benzene-exposed workers. Environ Mol Mutagen (2007) 1.17

Polymorphisms in cytokine and cellular adhesion molecule genes and susceptibility to hematotoxicity among workers exposed to benzene. Cancer Res (2005) 1.16

Polymorphisms in innate immunity genes and risk of non-Hodgkin lymphoma. Br J Haematol (2006) 1.16

Site-specific translocation and evidence of postnatal origin of the t(1;19) E2A-PBX1 fusion in childhood acute lymphoblastic leukemia. Proc Natl Acad Sci U S A (2002) 1.16

Genetic variation in the folate metabolic pathway and risk of childhood leukemia. Blood (2010) 1.14

Household exposure to paint and petroleum solvents, chromosomal translocations, and the risk of childhood leukemia. Environ Health Perspect (2008) 1.13

Performance in omics analyses of blood samples in long-term storage: opportunities for the exploitation of existing biobanks in environmental health research. Environ Health Perspect (2013) 1.13

The nature of chromosomal aberrations detected in humans exposed to benzene. Crit Rev Toxicol (2002) 1.12

The flavoring agent dihydrocoumarin reverses epigenetic silencing and inhibits sirtuin deacetylases. PLoS Genet (2005) 1.12

Bone marrow injury induced via oxidative stress in mice by inhalation exposure to formaldehyde. PLoS One (2013) 1.11

Occupational exposure to trichloroethylene is associated with a decline in lymphocyte subsets and soluble CD27 and CD30 markers. Carcinogenesis (2010) 1.10

Global gene expression profiling of a population exposed to a range of benzene levels. Environ Health Perspect (2010) 1.10

Large-scale evaluation of candidate genes identifies associations between DNA repair and genomic maintenance and development of benzene hematotoxicity. Carcinogenesis (2008) 1.10

Formaldehyde and leukemia: epidemiology, potential mechanisms, and implications for risk assessment. Environ Mol Mutagen (2010) 1.07

Risk of non-Hodgkin lymphoma associated with polymorphisms in folate-metabolizing genes. Cancer Epidemiol Biomarkers Prev (2005) 1.06

Single-cell multiplex gene detection and sequencing with microfluidically generated agarose emulsions. Angew Chem Int Ed Engl (2011) 1.06

Improving prediction of chemical carcinogenicity by considering multiple mechanisms and applying toxicogenomic approaches. Mutat Res (2008) 1.05

A functional TNFRSF5 gene variant is associated with risk of lymphoma. Blood (2008) 1.04

Evidence that humans metabolize benzene via two pathways. Environ Health Perspect (2009) 1.03

IARC monographs: 40 years of evaluating carcinogenic hazards to humans. Environ Health Perspect (2015) 1.03

Involvement of N-6 adenine-specific DNA methyltransferase 1 (N6AMT1) in arsenic biomethylation and its role in arsenic-induced toxicity. Environ Health Perspect (2010) 1.03

Chromosome-wide aneuploidy study (CWAS) in workers exposed to an established leukemogen, benzene. Carcinogenesis (2011) 1.03

Polymorphisms in genes involved in DNA double-strand break repair pathway and susceptibility to benzene-induced hematotoxicity. Carcinogenesis (2006) 1.02

Genetic polymorphisms and benzene metabolism in humans exposed to a wide range of air concentrations. Pharmacogenet Genomics (2007) 1.02

Decreased levels of CXC-chemokines in serum of benzene-exposed workers identified by array-based proteomics. Proc Natl Acad Sci U S A (2005) 1.02

Hypermethylation of the 5' CpG island of the FHIT gene is associated with hyperdiploid and translocation-negative subtypes of pediatric leukemia. Cancer Res (2004) 1.02

Changes in the peripheral blood transcriptome associated with occupational benzene exposure identified by cross-comparison on two microarray platforms. Genomics (2009) 1.01

Use of OctoChrome fluorescence in situ hybridization to detect specific aneuploidy among all 24 chromosomes in benzene-exposed workers. Chem Biol Interact (2005) 1.01

Building exposure biology centers to put the E into "G x E" interaction studies. Environ Health Perspect (2009) 1.01

Chromosome 12p deletions in TEL-AML1 childhood acute lymphoblastic leukemia are associated with retrotransposon elements and occur postnatally. Cancer Res (2008) 1.01

Polymorphisms and haplotypes in the cytochrome P450 17A1, prolactin, and catechol-O-methyltransferase genes and non-Hodgkin lymphoma risk. Cancer Epidemiol Biomarkers Prev (2005) 1.00

Systems biology of human benzene exposure. Chem Biol Interact (2009) 0.99

Comparative functional genomic analysis identifies distinct and overlapping sets of genes required for resistance to monomethylarsonous acid (MMAIII) and arsenite (AsIII) in yeast. Toxicol Sci (2009) 0.97

Prenatal origin of childhood acute myeloid leukemias harboring chromosomal rearrangements t(15;17) and inv(16). Blood (2003) 0.97

The histone deacetylase inhibitor trichostatin a has genotoxic effects in human lymphoblasts in vitro. Toxicol Sci (2006) 0.97

Prenatal origin of TEL-AML1-positive acute lymphoblastic leukemia in children born in California. Genes Chromosomes Cancer (2003) 0.96

Backtracking RAS mutations in high hyperdiploid childhood acute lymphoblastic leukemia. Blood Cells Mol Dis (2010) 0.95

Nonrandom aneuploidy of chromosomes 1, 5, 6, 7, 8, 9, 11, 12, and 21 induced by the benzene metabolites hydroquinone and benzenetriol. Environ Mol Mutagen (2005) 0.95

Formaldehyde and leukemia: an updated meta-analysis and evaluation of bias. J Occup Environ Med (2010) 0.95

High-throughput association testing on DNA pools to identify genetic variants that confer susceptibility to acute myeloid leukemia. Cancer Epidemiol Biomarkers Prev (2004) 0.95

Post-GWAS functional characterization of susceptibility variants for chronic lymphocytic leukemia. PLoS One (2012) 0.94

Association of HLA-DQB1 alleles with risk of follicular lymphoma. Leuk Lymphoma (2010) 0.94

Non-linear production of benzene oxide-albumin adducts with human exposure to benzene. J Chromatogr B Analyt Technol Biomed Life Sci (2002) 0.93

Tobacco smoke exposure and the risk of childhood acute lymphoblastic and myeloid leukemias by cytogenetic subtype. Cancer Epidemiol Biomarkers Prev (2013) 0.92

Towards incorporating epigenetic mechanisms into carcinogen identification and evaluation. Carcinogenesis (2013) 0.92

Genome-wide functional profiling reveals genes required for tolerance to benzene metabolites in yeast. PLoS One (2011) 0.91

Associations of non-Hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL loci. Am J Epidemiol (2015) 0.91

Micronucleus frequency and proliferation in human lymphocytes after exposure to herbicide 2,4-dichlorophenoxyacetic acid in vitro and in vivo. Mutat Res (2002) 0.90

Leukaemia-specific chromosome damage detected by comet with fluorescence in situ hybridization (comet-FISH). Mutagenesis (2007) 0.90

Microarray analysis of gene expression in peripheral blood mononuclear cells from dioxin-exposed human subjects. Toxicology (2006) 0.90

Protein adducts as biomarkers of human benzene metabolism. Chem Biol Interact (2005) 0.90

Prenatal origin of chromosomal translocations in acute childhood leukemia: implications and future directions. Am J Hematol (2004) 0.89

Elevated urinary levels of kidney injury molecule-1 among Chinese factory workers exposed to trichloroethylene. Carcinogenesis (2012) 0.89

Rapid determination of six urinary benzene metabolites in occupationally exposed and unexposed subjects. Anal Biochem (2004) 0.89

PRRC2A and BCL2L11 gene variants influence risk of non-Hodgkin lymphoma: results from the InterLymph consortium. Blood (2012) 0.89

Albumin adducts of electrophilic benzene metabolites in benzene-exposed and control workers. Environ Health Perspect (2007) 0.88

Single molecule quantitation and sequencing of rare translocations using microfluidic nested digital PCR. Nucleic Acids Res (2013) 0.88

Use of 'Omic' technologies to study humans exposed to benzene. Chem Biol Interact (2005) 0.88

Screening the human serum proteome for genotype-phenotype associations: an analysis of the IL6 -174G>C polymorphism. Proteomics (2007) 0.88

Werner syndrome protein, WRN, protects cells from DNA damage induced by the benzene metabolite hydroquinone. Toxicol Sci (2008) 0.88

Association of genetic variation in cystathionine-beta-synthase and arsenic metabolism. Environ Res (2010) 0.88

Polymorphisms in ghrelin and neuropeptide Y genes are associated with non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev (2005) 0.88